New Washington law sets $100 cap on copayments for insulin

A new law in Washington state will impose a $100 cap on patient copayments for insulin. The copay cap, which lasts through 2021 and 2022, includes language to protect people who have high-deductible insurance from paying more than $100 per 30-day supply. The law was approved by the state’s legislature in March to ease a crisis that can lead to medical complications. The American Diabetes Association (ADA) has praised the Washington law and urges state governors “to ensure continuous access to health care for residents with diabetes who have lost their jobs to the economic impact of the pandemic.” The ADA lists seven states as having approved copay caps as of spring 2020: Washington, Colorado, Illinois, Maine, New Mexico, New York, Utah and West Virginia.